Healthcare Equipment and Supplies
Company Overview of Barosense, Inc.
Barosense, Inc. manufactures minimally invasive medical devices for the treatment of obesity for obesity sufferers. It develops minimally invasive therapeutic weight loss procedures and devices, including investigational trans-oral endoscopic restrictive implant system and a trans-oral (through the mouth) procedure that places a soft (tissue) silicone device in the stomach that induces a feeling of fullness with a small meal. Barosense, Inc. was founded in 2001 and is based in Redwood City, California.
250 Chesapeake Drive
Redwood City, CA 94063
Founded in 2001
Key Executives for Barosense, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Barosense, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.